Uptake and Population-Level Impact of Expedited Partner Therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: The Washington State Community-Level Randomized Trial of EPT

PLoS Medicine

Volumn 12, Issue 1, 2015, Pages 1-22

  Golden, Matthew R ^a,b   Kerani, Roxanne P ^a,b   Stenger, Mark ^c   Hughes, James P ^a   Aubin, Mark ^c   Malinski, Cheryl ^a   Holmes, King K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHEMOPROPHYLAXIS; CHLAMYDIASIS; CONTROLLED STUDY; EXPEDITED PARTNER THERAPY; FEMALE; GONORRHEA; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT DELIVERED PARTNER THERAPY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTACT EXAMINATION; HETEROSEXUALITY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; NEISSERIA GONORRHOEAE; PREVALENCE; SEXUALITY; SEXUALLY TRANSMITTED DISEASES; TRANSMISSION; WASHINGTON;

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CONTACT TRACING; FEMALE; GONORRHEA; HETEROSEXUALITY; HUMANS; NEISSERIA GONORRHOEAE; PREVALENCE; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; WASHINGTON; YOUNG ADULT;

EID: 84923849868     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001777     Document Type: Article

References (47)

1. Centers for Disease Control and Prevention (2013) Sexually transmitted disease surveillance 2012. Atlanta: Centers for Disease Control and Prevention. 25512673
2. Golden MR, Hogben M, Potterat JJ, Handsfield HH, (2004) HIV partner notification in the United States: a national survey of program coverage and outcomes. Sex Transm Dis 31: 709–712. 15608584
3. Schillinger JA, Kissinger P, Calvet H, Whittington WL, Ransom RL, et al. (2003) Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 30: 49–56. 12514443
4. Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE, et al. (2005) Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 352: 676–685. 15716561
5. Kissinger P, Mohammed H, Richardson-Alston G, Leichliter JS, Taylor SN, et al. (2005) Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 41: 623–629. 16080084
6. Ferreira A, Young T, Mathews C, Zunza M, Low N, (2013) Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev 10: CD002843. doi: 10.1002/14651858.CD002843.pub2 24092529
7. Centers for Disease Control and Prevention (2014) Legal status of expedited partner therapy (EPT). Atlanta: Centers for Disease Control and Prevention 23859917
8. Hogben M, McCree DH, Golden MR, (2005) Patient-delivered partner therapy for sexually transmitted diseases as practiced by U.S. physicians. Sex Transm Dis 32: 101–105. 15668616
9. Guerry SL, Bauer HM, Packel L, Samuel M, Chow J, et al. (2005) Chlamydia screening and management practices of primary care physicians and nurse practitioners in California. J Gen Intern Med 20: 1102–1107. 16423098
10. Rogers ME, Opdyke KM, Blank S, Schillinger JA, (2006) Patient-delivered partner treatment and other partner management strategies for sexually transmitted diseases used by New York City healthcare providers. Sex Transm Dis 34: 88–92. 16810120
11. Cramer R, Leichliter JS, Stenger MR, Loosier PS, Slive L, et al. (2013) The legal aspects of expedited partner therapy practice: do state laws and policies really matter? Sex Transm Dis 40: 657–662. doi: 10.1097/01.OLQ.0000431358.18959.d4 23859917
12. Golden MR, Hughes JP, Brewer DD, Holmes KK, Whittington WL, et al. (2007) Evaluation of a population-based program of expedited partner therapy for gonorrhea and chlamydial infection. Sex Transm Dis 34: 598–603. 17413683
13. Yu YY, Frasure-Williams JA, Dunne EF, Bolan G, Markowitz L, et al. (2011) Chlamydia partner services for females in California family planning clinics. Sex Transm Dis 38: 913–918. doi: 10.1097/OLQ.0b013e3182240366 21934563
14. Stephens SC, Bernstein KT, Katz MH, Philip SS, Klausner JD, (2010) The effectiveness of patient-delivered partner therapy and chlamydial and gonococcal reinfection in San Francisco. Sex Transm Dis 37: 525–529. doi: 10.1097/OLQ.0b013e3181d8920f 20502392
15. Mickiewicz T, Al-Tayyib A, Thrun M, Rietmeijer C, (2012) Implementation and effectiveness of an expedited partner therapy program in an urban clinic. Sex Transm Dis 39: 923–929. doi: 10.1097/OLQ.0b013e3182756f20 23169171
16. Kerns JL, Jones HE, Pressman EJ, Fratarelli LA, Garth J, et al. (2011) Implementation of expedited partner therapy among women with chlamydia infection at an urban family planning clinic. Sex Transm Dis 38: 722–726. doi: 10.1097/OLQ.0b013e318214bb83 21844724
17. Hussey MA, Hughes JP, (2007) Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 28: 182–191. 16829207
18. Golden MR, Whittington WL, Handsfield HH, Malinski C, Clark A, et al. (2001) Partner management for gonococcal and chlamydial infection: expansion of public health services to the private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis 28: 658–665. 11677389
19. Washington State Department of Health (2005) Washington State provider guidelines for patient delivered therapy. Olympia: Washington State Department of Health. 15838410
20. Satterwhite CL, Grier L, Patzer R, Weinstock H, Howards PP, et al. (2011) Chlamydia positivity trends among women attending family planning clinics: United States, 2004–2008. Sex Transm Dis 38: 989–994. doi: 10.1097/OLQ.0b013e318225f7d7 21992972
21. Centers for Disease Control and Prevention (2010) Sexually transmitted disease surveillance 2009. Atlanta: Centers for Disease Control and Prevention.
22. Fine D, Dicker L, Mosure D, Berman S, (2008) Increasing chlamydia positivity in women screened in family planning clinics: do we know why? Sex Transm Dis 35: 47–52. 17700377
23. Centers for Disease Control and Prevention (2009) CDC expert consultation on the effect of antiretroviral therapy on risk of sexual transmission of HIV infection and superinfection. Atlanta: Centers for Disease Control and Prevention.
24. Groves RM, Mosher WD, Lepkowski JM, Kirgis NG, (2009) Planning and development of the continuous National Survey of Family Growth. Vital Health Stat 1: 1–64. 20141029
25. Kissinger P, Schmidt N, Mohammed H, Leichliter JS, Gift TL, et al. (2006) Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis 33: 445–450. 16531939
26. Cameron ST, Glasier A, Scott G, Young H, Melvin L, et al. (2009) Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial. Hum Reprod 24: 888–895. doi: 10.1093/humrep/den475 19136481
27. Althaus CL, Turner KM, Mercer CH, Auguste P, Roberts TE, et al. (2014) Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling. Health Technol Assess 18: 1–100. doi: 10.3310/hta18020 24411488
28. Kretzschmar M, van Duynhoven YT, Severijnen AJ, (1996) Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. Am J Epidemiol 144: 306–317. 8686700
29. Hethcote H, Yorke J, Nold A, (1982) Gonorrhea modeling. Math Biosci 58: 93–109.
30. US Department of Health and Human Services Public Health Service, Centers for Disease Control and Prevention National Center for HIV, STD, and TB Prevention (2006) Expedited partner therapy in the management of sexually transmitted diseases: review and guidance.Washington (District of Columbia): US Department of Health and Human Services.
31. New Mexico Department of Health (2007) New Mexico Department of Health guidelines for expedited partner treatment (EPT) of sexually transmitted diseases. Santa Fe: New Mexico Department of Health.
32. Minnesota Department of Health (2008) Expedited partner therapy (EPT) for Chlamydia trachomatis and Neisseria gonorrhoeae: guidance for medical providers in Minnesota. Minneapolis: Minnesota Department of Health. doi: 10.1097/OLQ.0b013e31815b0158 18166849
33. Bauer HM, Wohlfeiler D, Klausner JD, Guerry S, Gunn RA, et al. (2008) California guidelines for expedited partner therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis 35: 314–319. doi: 10.1097/OLQ.0b013e31815b0158 18166849
34. New York State Department of Health (2011) Expedited partner therapy guidelines for health care providers in NYS for Chlamydia trachomatis. Albany: New York State Department of Health.
35. Tennessee Department of Health (2013) Expedited STD management implementation guide. Nashville: Tennessee Department of Health.
36. Gift TL, Kissinger P, Mohammed H, Leichliter JS, Hogben M, et al. (2011) The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of Chlamydia or gonorrhea. Sex Transm Dis 38: 1067–1073. doi: 10.1097/OLQ.0b013e31822e9192 21992986
37. Ng BE, Butler LM, Horvath T, Rutherford GW, (2011) Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev 2011: CD001220. doi: 10.1002/14651858.CD001220.pub3 21412869
38. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, et al. (1995) Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 346: 530–536. 7658778
39. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, et al. (2003) Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 361: 645–652. 12606175
40. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 353: 525–535. 10028980
41. Garcia PJ, Holmes KK, Carcamo CP, Garnett GP, Hughes JP, et al. (2012) Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet 379: 1120–1128. doi: 10.1016/S0140-6736(11)61846-1 22341824
42. van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Gotz HM, et al. (2012) Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ 345: e4316. doi: 10.1136/bmj.e4316 22767614
43. Centers for Disease Control and Prevention (2012) Update to CDC’s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 61: 590–594. 22874837
44. Unemo M, European STI Guidelines Editorial Board (2012) The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy. Euro Surveill 17: 20323. 23231859
45. Centers for Disease Control and Prevention (2013) Guidance on the use of expedited partner therapy in the treatment of gonorrhea. Atlanta: Centers for Disease Control and Prevention. 18987617
46. Golden MR, Barbee LA, Kerani R, Dombrowski JC, (2014) Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae. Sex Transm Dis 41: 619–625. doi: 10.1097/OLQ.0000000000000174 25211259
47. Campbell MK, Elbourne DR, Altman DG, CONSORT Group (2005) CONSORT statement: extension to cluster randomised trials. BMJ 328: 702–708. 22951546